Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Connection

Alok Singh to Mycobacterium tuberculosis

This is a "connection" page, showing publications Alok Singh has written about Mycobacterium tuberculosis.

 
Connection Strength
 
 
 
1.654
 
  1. Singh AK, Yadav P, Karaulia P, Singh VK, Gupta P, Puttrevu SK, Chauhan S, Bhatta RS, Tadigoppula N, Gupta UD, Chopra S, Dasgupta A. Biological evaluation of novel curcumin-pyrazole-mannich derivative active against drug-resistant Mycobacterium tuberculosis. Future Microbiol. 2017 11; 12:1349-1362.
    View in: PubMed
    Score: 0.439
  2. Singh AK, Karaulia P, Yadav P, Narender T, Singh SP, Sashidhara KV, Pandey AK, Chopra S, Dasgupta A. Identification of lipid metabolism-targeting compounds active against drug-resistant M. tuberculosis. J Glob Antimicrob Resist. 2016 12; 7:26-27.
    View in: PubMed
    Score: 0.405
  3. Rohilla A, Singh AK, Koleske B, Srikrishna G, Bishai WR. Structure-based virtual screening and in vitro validation of inhibitors of cyclic dinucleotide phosphodiesterases ENPP1 and CdnP. Microbiol Spectr. 2024 Jan 11; 12(1):e0201223.
    View in: PubMed
    Score: 0.168
  4. Bullen CK, Singh AK, Krug S, Lun S, Thakur P, Srikrishna G, Bishai WR. MDA5 RNA-sensing pathway activation by Mycobacterium tuberculosis promotes innate immune subversion and pathogen survival. JCI Insight. 2023 10 23; 8(20).
    View in: PubMed
    Score: 0.167
  5. Choudhary E, Bullen CK, Goel R, Singh AK, Praharaj M, Thakur P, Dhiman R, Bishai WR, Agarwal N. Relative and Quantitative Phosphoproteome Analysis of Macrophages in Response to Infection by Virulent and Avirulent Mycobacteria Reveals a Distinct Role of the Cytosolic RNA Sensor RIG-I in Mycobacterium tuberculosis Pathogenesis. J Proteome Res. 2020 06 05; 19(6):2316-2336.
    View in: PubMed
    Score: 0.131
  6. Kumar A, Boradia VM, Thakare R, Singh AK, Gani Z, Das S, Patidar A, Dasgupta A, Chopra S, Raje M, Raje CI. Repurposing ethyl bromopyruvate as a broad-spectrum antibacterial. J Antimicrob Chemother. 2019 04 01; 74(4):912-920.
    View in: PubMed
    Score: 0.122
  7. Pandey M, Singh AK, Thakare R, Talwar S, Karaulia P, Dasgupta A, Chopra S, Pandey AK. Diphenyleneiodonium chloride (DPIC) displays broad-spectrum bactericidal activity. Sci Rep. 2017 09 14; 7(1):11521.
    View in: PubMed
    Score: 0.109
  8. Singh M, Sarhan MO, Damiba NNL, Singh AK, Villabona-Rueda A, Nino-Meza OJ, Chen X, Masias-Leon Y, Ruiz-Gonzalez CE, Ordonez AA, D'Alessio FR, Aboagye EO, Carroll LS, Jain SK. Proapoptotic Bcl-2 inhibitor as potential host directed therapy for pulmonary tuberculosis. Nat Commun. 2025 Mar 27; 16(1):3003.
    View in: PubMed
    Score: 0.046
  9. Shariq M, Quadir N, Sheikh JA, Singh AK, Bishai WR, Ehtesham NZ, Hasnain SE. Post translational modifications in tuberculosis: ubiquitination paradox. Autophagy. 2021 03; 17(3):814-817.
    View in: PubMed
    Score: 0.034
  10. Dey RJ, Dey B, Singh AK, Praharaj M, Bishai W. Bacillus Calmette-Guérin Overexpressing an Endogenous Stimulator of Interferon Genes Agonist Provides Enhanced Protection Against Pulmonary Tuberculosis. J Infect Dis. 2020 03 16; 221(7):1048-1056.
    View in: PubMed
    Score: 0.032
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)